STARLinG specifications

Information


Unique identifier OMICS_30206
Name STARLinG
Alternative name SNPs to Target Genes
Restrictions to use None
Community driven No
Data access File download
User data submission Not allowed
Maintained Yes

Taxon


  • Primates
    • Homo sapiens

Maintainers


  • person_outline Brent Richards
  • person_outline David Evans

Publication for SNPs to Target Genes

STARLinG citations

 (2)
library_books

Using regulatory genomics data to interpret the function of disease variants and prioritise genes from expression studies

2018
F1000Res
PMCID: 5850119
PMID: 29568492
DOI: 10.5256/f1000research.14748.r30355

[…] ncer elements across a large panel of tissues and cell types can then be calculated to identify significant promoter - enhancer pairs. In turn, we will use these correlations to map distal regulatory SNPs to target genes.Let's read in the enhancer - promoter correlation data: # uncomment the following line to download the file #download.file("http://enhancer.binf.ku.dk/presets/enhancer_tss_associ […]

library_books

Systems Genetic Validation of the SNP Metabolite Association in Rice Via Metabolite Pathway Based Phenome Wide Association Scans

2015
Front Plant Sci
PMCID: 4661230
PMID: 26640468
DOI: 10.3389/fpls.2015.01027

[…] s analyzed in parallel using two methods. First, a pathway enrichment analysis was conducted to determine the related Upper Tier Metabolite Pathway (UTMP). Second, eQTL information was used to direct SNPs to target genes and enzymes. The identified UTMP pathway was then searched for targeted enzymes upstream of the target metabolite. The consistency of the enzyme level and downstream metabolite le […]

STARLinG institution(s)
Department of Human Genetics, McGill University, Montréal, QC, Canada; Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, QC, Canada; [etc.]
STARLinG funding source(s)
Supported by the Canadian Institutes of Health Research, the Canadian Foundation for Innovation, the Fonds de Recherche Santé Québec (FRSQ) a FRQS Clinical Research Scholarship, the Wellcome Trust, Medical Research Council, European Union, the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London, the Canadian Institutes of Health Research, a National Health and Medical Research Council Senior Research Fellowship (APP1137714), a Medical Research Council Programme Grant (MC_UU_12013/4), a University of Queensland Development Fellowship, an Arthritis Research UK (ref; 20000), the Wellcome Trust (Strategic Award grant number 101123; project grant 094134), the Mrs Janice Gibson and the Ernest Heine Family Foundation, Israel Science Foundation grant #1283/14, US NIH NIAMS 1R01AR072199, the Netherlands Organization for Health Research and Development (ZonMw VIDI 016.136.361 grant), NIH/NIAMS AR063702 AR060981, the National Institute of Arthritis Musculoskeletal and Skin Diseases R01 AR041398, R01 AR072199, the Australian Government Research Training Program Scholarship, the Genetic Factors of Osteoporosis GEFOS EU FP7 Integrated Project Grant Reference: 201865 2008-12 and 2007-12 UK NIHR Biomedical Research Centre Grant (Musculoskeletal theme) to Cambridge Clinical School, the Swedish Research Council, Swedish Foundation for Strategic Research, the Sahlgrenska University Hospital, Lundberg Foundation, European Calcified Tissue Society, Torsten and Ragnar Söderberg’s Foundation, Novo Nordisk Foundation, and the Knut and Alice Wallenberg Foundation.

STARLinG reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review STARLinG